Diagnosing NTM and Bronchiectasis: Best Practices for Early and Accurate Recognition
ABOUT THIS EPISODE
Originally aired: March 25, 2025
Early recognition and diagnosis of nontuberculous mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions are often misdiagnosed as COPD or asthma, leading to significant challenges and delays in treatment. Join Nathan Falk, MD, MBA, and Ashwin Basavaraj, MD, FCCP, as they share perspectives on accurately diagnosing NTM and bronchiectasis with early symptom recognition, a thorough patient history, and testing.
This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis program. LEARN MORE »
This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.
HOST
Nathan Falk, MD, MBA
Board-Certified Family Medicine Physician
Professor and Founding Residency Director
Family Medicine at Florida State University, BayCare Health System
Assistant Dean for Graduate Medical Education
Florida State University
Winter Haven, FL
PANELIST
Ashwin Basavaraj, MD, FCCP
Associate Professor of Medicine
NYU Grossman School of Medicine
Director of the Bronchiectasis and NTM Education Program
NYU Langone Health
Section Chief of Pulmonary, Critical Care, and Sleep Medicine
Bellevue Hospital Center
New York, NY